🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Tablet(s) Serving Size
30 Servings
Botanical with Nutrients Product Type
43% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrates
2 g (1% DV)
7.5 mg (500% DV)
📊 6.2× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 7.5mg
10 mg (500% DV)
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
500 mg (125% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg
10 mg (500% DV)
📊 4.3× RDA — above typical dose (UL: 11 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 10mg UL 11mg
Malic Acid
1.5 g
ActiSorb Base
10 mg

Other Ingredients

Cellulose Stearic Acid Silica

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

4 daily

Directions: Use only as directed. Take 4 tablets daily with a meal.

⚠️ Warnings & Precautions

Warning: Do not use if safety seal is broken or missing.

Keep out of reach of children.

Keep your licensed health care practitioner informed when using this product.

🧪 Formulation Notes

1500 mg Malic Acid

Clear Quality

Enhanced Absorption

Discussion: Malic Acid and Magnesium are essential to the production of cellular energy.

These two substances are also active in the Krebs cycle and provide nutritive support for normal, healthy muscular energy. The exclusive KAL ActiSorb Base helps enhance absorption by stimulating gastric secretion and the body's natural thermogenic activity.

KAL Guarantees that no ingredients other than those listed on this label have been added to this product.

Additional Information

KAL Innovative quality since 1932

Store in a cool, dry place.

ActivTab technology guarantees tablet disintegration within 30 minutes according to USP standards.

Product Details

UPC / SKU 0 21245 74590 7
DSLD Entry Date 2021-09-24
Product Type Botanical with Nutrients
Form Tablet or Pill
Brand KAL
DSLD ID 253228
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →